Next Generation DNA Synthesis
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
89
NCT02508441
Phase 1 Safety and Tolerability Study of Andes-1537 for Injection in Patients With Advanced Unresectable Solid Tumors
Phase: Phase 1
Role: Lead Sponsor
Start: Dec 8, 2015
Completion: Nov 13, 2017
NCT03985072
Study With Andes-1537 in Patients With Specific Types of Advanced Solid Tumor
Start: Apr 26, 2019
Completion: Feb 17, 2022
Loading map...